Lampard Inquiry chair considers interim findings on Essex mental health deaths

The Lampard Inquiry, chaired by Baroness Kate Lampard, is investigating the deaths of over 2,000 mental health patients in Essex between 2000 and 2023. The inquiry is considering issuing urgent interim recommendations regarding inpatient safety, focusing on staff CPR training and the controversial Oxevision digital monitoring system. While developer LIO Health defends the technology, families and legal representatives argue that the invasive 24-hour camera system compromises privacy and dangerously replaces direct human care.

Interim recommendations of the Lampard Inquiry

• ▪The Lampard Inquiry chair, Baroness Kate Lampard, announced she will issue interim recommendations if she identifies issues posing an urgent risk to patient safety.
• ▪The Lampard Inquiry's expected interim recommendations will focus on inpatient safety, specifically highlighting resuscitation procedures alongside patient monitoring technology.
• ▪Affected families will be invited to share their views on potential interim recommendations during a virtual hearing scheduled for October 20, 2026.

Lampard Inquiry timeline and scope

• ▪The Lampard Inquiry is investigating the deaths of more than 2,000 people who died while under the care of Essex mental health services between 2000 and the end of 2023.
• ▪The Lampard Inquiry is scheduled to hear evidence from NHS England, the Care Quality Commission, and the Medicines and Healthcare products Regulatory Agency between October 5 and October 15, 2026.
• ▪The final report of the Lampard Inquiry, which could carry national implications for mental health units across England, is not expected to be published until 2028.

Legal representation

• ▪Nina Ali, a partner at Hodge Jones & Allen, represents 120 affected families in the Lampard Inquiry proceedings.
• ▪Legal representative Nina Ali called for all mental health facility staff to undergo face-to-face CPR training delivered by an independent body, with those who fail being removed from patient care.

Debate over Oxevision monitoring technology

• ▪The Oxevision patient-monitoring system, which tracks movement and calculates pulse and respiration rates, has been adopted by 50 percent of mental health trusts across England.
• ▪Campaign groups and legal representatives argue that Oxevision presents safety risks, claiming care staff have substituted direct human observations with digital monitoring, leading to fatal consequences.
• ▪NHS England stated that any vision-based monitoring technology must support a human rights-based approach to care and comply with legal requirements and patient consent.
• ▪LIO Health, the developer of Oxevision, stated that the technology helps prevent serious incidents, supports staff in providing care, and reduces time spent on administrative paperwork.
• ▪Legal representatives from Bindmans, acting for the Stop Oxevision campaign, urged the Information Commissioner’s Office to inspect whether Oxevision's patient data collection complies with the law.

Death of Sophie Alderman

• ▪Tammy Smith, the mother of Sophie Alderman, stated that the digital monitoring was unsafe, worsened her daughter's paranoia, and failed to protect her when the alert function was not answered.
• ▪Sophie Alderman, a 27-year-old with a history of severe mental illness, died by suicide in August 2022 at Rochford Hospital in Essex while being monitored by the Oxevision system.

Debatable claims

• ▪Mandatory patient consent is necessary for digital monitoring in mental health wards
• ▪Mental health staff who fail independent CPR training should be removed from patient care
• ▪Oxevision patient monitoring does more harm than good in mental health wards